Identification and Prognostic Analysis of Immune-Related Genes Co-Regulated by Key Histone Modifications in Breast Cancer
Current Issues in Molecular Biology · 01.06.2026 · 48 (6) · 582
DOI: 10.3390/cimb48060582 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 01.06.2026. Verfasst von Yanni Cao und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Artificial Intelligence, Anhui University of Science & Technology, Huainan 232001, China. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anhui Provincial Department of Education, National Natural Science Foundation of China, Natural Science Research Project of Anhui Educational Committee.
Abstract (Originalsprache)
Background
Breast cancer (BRCA) is a common malignant tumor that seriously threatens women’s health. Studies have shown that histone modifications (HMs) play a vital role in the occurrence and development of BRCA. This study aims to explore the distribution patterns of HMs in the mammary epithelial cell line (HMEC) and breast cancer cell line (MCF-7), and their potential associations with gene expression, patient prognosis, and drug efficacy.
Methods
First, the distribution of histone modification (HM) signals in HMEC and MCF-7 cell lines was analyzed. Multiple algorithms were then used to predict the effects of different HMs and their modified regions on gene expression in the two cell lines. Based on four key regions identified from this analysis, 268 HM-related immune-related genes (H_IRGs) were screened, followed by functional enrichment and pathway analysis. Subsequently, Cox and LASSO regression analyses were performed on the H_IRGs to construct a risk scoring model.
Results
The random forest algorithm showed the best predictive performance (AUC = 0.92) and identified three key HMs (H3K4me2, H3K27me3, and H3K36me3) and four key regions that strongly influenced gene expression. A risk scoring model was constructed from 11 key IRGs (BCL2A1, PSME2, STC2, ESRRG, CRISP3, IL13RA1, LCN1, EED, CLEC10A, SLURP1, and FGF12). This model effectively predicted patients’ survival in both the training and validation cohorts.
Conclusions
In summary, our research results provide a theoretical basis for the occurrence and development of BRCA, and the 11 key IRGs discovered are expected to become potential biomarkers for BRCA prognostic assessment and treatment response prediction.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Artificial Intelligence, Anhui University of Science & Technology, Huainan 232001, China.
- State Key Laboratory of Digital Intelligent Technology for Unmanned Coal Mining, Anhui University of Science & Technology, Huainan 232001, China.
- Center for Informational Biology, School of Life Sciences and Technology, University of Electronic Science and Technology of China, Chengdu 611731, China.
Förderung
- Anhui Provincial Department of Education
- National Natural Science Foundation of China
- Natural Science Research Project of Anhui Educational Committee
Zitieren
APA
Cao, Y., Li, X., Liu, J., Zhang, J., Xu, K., Lin, H., & Liu, Y. (2026). Identification and Prognostic Analysis of Immune-Related Genes Co-Regulated by Key Histone Modifications in Breast Cancer. Current Issues in Molecular Biology, 48(6), 582. https://doi.org/10.3390/cimb48060582
Vancouver
Cao Y, Li X, Liu J, Zhang J, Xu K, Lin H, et al. Identification and Prognostic Analysis of Immune-Related Genes Co-Regulated by Key Histone Modifications in Breast Cancer. Current Issues in Molecular Biology. 2026;48(6):582. doi:10.3390/cimb48060582
BibTeX
@article{Cao2026,
author = {Cao, Yanni and Li, Xiaohui and Liu, Jiangshan and Zhang, Junyuan and Xu, Kangcheng and Lin, Hao and Liu, Yuxian},
title = {Identification and Prognostic Analysis of Immune-Related Genes Co-Regulated by Key Histone Modifications in Breast Cancer},
journal = {Current Issues in Molecular Biology},
year = {2026},
volume = {48},
number = {6},
pages = {582},
doi = {10.3390/cimb48060582}
}
EUVIMED